XML 91 R66.htm IDEA: XBRL DOCUMENT
v2.4.0.6

Business segment information (Details 2) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2011 | Sep. 30, 2011 | Jun. 30, 2011 | Mar. 31, 2011 | Dec. 31, 2010 | Sep. 30, 2010 | Jun. 30, 2010 | Mar. 31, 2010 | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2009
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales | $ 151,525 | $ 144,747 | $ 143,551 | $ 139,165 | $ 143,796 | $ 138,906 | $ 142,845 | $ 138,823 | $ 578,988 | $ 564,370 | $ 545,635
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 100.00% | 100.00% | 100.00%
Strategic Products |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | 573,161 | 551,093 | 515,175
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 99.00% | 98.00% | 94.00%
Spine Products |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | 304,217 | 306,404 | 279,425
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 52.00% | 54.00% | 51.00%
Implants and Biologics |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | 143,775 | 133,831 | 120,445
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 24.00% | 23.00% | 22.00%
Stimulation |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | 160,442 | 172,573 | 158,980
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 28.00% | 31.00% | 29.00%
Orthopedics Products |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | 165,904 | 149,175 | 139,304
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 29.00% | 26.00% | 25.00%
Sports Medicine Products |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | 103,040 | 95,514 | 96,446
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 18.00% | 18.00% | 18.00%
Divested Products |  |  |  |  |  |  |  |  |  |  |
Market sector information |  |  |  |  |  |  |  |  |  |  |
Total Net Sales |  |  |  |  |  |  |  |  | $ 5,827 | $ 13,277 | $ 30,460
Percent of Total Net Sales |  |  |  |  |  |  |  |  | 1.00% | 2.00% | 6.00%

X
- Definition Represents the revenues of a market sector as a percent of total revenues of the reporting entity. + References No definition available. + Details
Name: | ofix_PercentOfMarketSectorRevenuesToTotalRevenues
Namespace Prefix: | ofix_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 5 -Section 03 -Paragraph 1 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration